Study Details
A paediatric, open, follow up study with Modigraf examining safety and efficacy in de novo allograft recipients
Clinicaltrials.gov ID
Astellas Study ID
F506-CL-0404
EudraCT ID
2009-012259-21
Condition
Heart Transplants, Kidney Transplants, Liver Transplants
Phase
Phase 4
Age
0 years - 12 years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Jun 2011 - Apr 2017
Masking
None (Open Label)
Enrollment number
47
A Long-term, Open-label, Non-comparative Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in Paediatric Solid Allograft Recipients
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A paediatric, open, follow up study with Modigraf examining safety and efficacy in de novo allograft recipients? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site FR60 Groupement Hospitalier EST
Bron, France, 69677
Site ES23 Hospital Universitario La Paz
Madrid, Spain, 28046
Site ES20 Hospital Universitario La Paz
Madrid, Spain, 28046
Site FR61 Hopital Robert Debre
Paris Cedex 19, France, 75945
Site GB11 Great Ormond Street Hospital
London, United Kingdom, WC1N3JH
Site GB14 Alder Hey Children Hospital
Liverpool, United Kingdom, L12 2AP
Site ES22 H.U. Gregorio Maranon
Madrid, Spain, 28007
Site BE41 U.Z. Leuven
Leuven, Belgium, 3000
Site DE30 Universitätsklin Heidelberg
Heidelberg, Germany, 69120
Site ES21 Hospital Universitario La Paz
Madrid, Spain, 28046
Site BE40 Clinique Univ. Saint Luc
Brussels, Belgium, 1200
Site GB13 Cent. Manchester Uni. Hospital
Manchester, United Kingdom, M13 9WL
Site DE31 Kliniken der Medizinischen Hoc
Hannover, Germany, 30625
Site GB10 Birmingham Children's Hospital
Birmingham, United Kingdom, B4 6NH
Site PL50 Centrum Zdrowia Dziecka
Warsaw, Poland, 04-730